Avantor

General Information
Business:

 

We are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our comprehensive offerings, which include materials & consumables, equipment & instrumentation and services & specialty procurement, are relied upon by our customers, often on a recurring basis, because they are frequently specified into their research, development and production processes. These processes are commonly organized into “workflows” that define the activities our customers perform each day.

Industry: LABORATORY ANALYTICAL INSTRUMENTS
Employees: 12000
Founded: 1904
Contact Information
Address Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087, US
Phone Number (610) 386-1700
Web Address http://www.avantorinc.com
View Prospectus: Avantor
Financial Information
Market Cap $7480.1mil
Revenues $5926.1 mil (last 12 months)
Net Income $-51.9 mil (last 12 months)
IPO Profile
Symbol AVTR
Exchange NYSE
Shares (millions): 207.0
Price range $14.00 - $14.00
Est. $ Volume $2898.0 mil
Manager / Joint Managers Goldman Sachs/ J.P. Morgan/ BofA Merrill Lynch/ Barclays/ Jefferies
CO-Managers Credit Suisse/ Deutsche Bank Securities/ Evercore ISI/ Guggenheim Securities/ Morgan Stanley/ UBS Investment Bank/ Citigroup/ Cowen/ Piper Jaffray/ RBC Capital Markets/ Baird/ William Blair/ Janney Montgomery Scott/ KeyBanc Capital Markets/ PJT Partners/ Raymond James/ Stephens/ Stifel/ SunTrust Robinson Humphrey/ Wells Fargo Securities/ Drexel Hamilton
Expected To Trade: 5/17/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change